1. Ludwig Institute for Cancer Research Limited (19 from 525 patents)

2. Cornell Research Foundation Inc. (7 from 1,521 patents)

3. Memorial Sloan Kettering Cancer Center (5 from 559 patents)

4. Other (4 from 832,680 patents)

1. 8541202 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein

2. 8142786 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein

3. 8071717 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

4. 7888100 - Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein

5. 7795409 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof

6. 7795379 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

7. 7622568 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

8. 7354992 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

9. 7291335 - Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof

10. 7132507 - Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses

11. 7125681 - Methods for detection of disease-associated antibodies in urine

12. 7115729 - Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53

13. 7009035 - Isolated peptides which bind to HLA-C molecules and uses thereof

14. 6911529 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

15. 6830924 - Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof